Found 5 matching trials
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®
PHASE1Therapeutic indication: Ocular hypotensive Use: Primary open-angle glaucoma...
Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide
PHASE2To compare intraocular pressure lowering effectiveness of a new fixed combi...
Location
Instituto de la Visión. Hospital Universitario La Carlota. Universidad de Montemorelos
Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
PHASE4Phase IV randomized, double blind, multicenter, parallel group clinical stu...
Location
Servicios Médicos y de Investigación Clínica InspirePharma S. de R.L.de C.V.
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
PHASE3Objectives: To evaluate the non-inferiority in the intraocular pressure dec...
Location
MD. Sandra Belalcazar Rey
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)
PHASE3Aim: To demonstrate the non-inferiority of the PRO-122 ophthalmic solution ...
Location
Multiple Locations